Mental, Behavioral and Development Health

A recent study finds kangaroo care boosts brain development in premature infants, showing even brief skin-to-skin contact leads to better cognitive outcomes at 1 year.

The survey report shed light on the crucial role of bedtime routines in children aged 1-6 years. The findings of the survey emphasized the significance of establishing consistent bedtime routines for children in this age group.

How can tablet use contribute to expressions of anger and frustration among children aged 3.5 to 5.5 years?

Get caught up with our journal! Review some of the top stories from the Contemporary Pediatrics website over the last week, and catch up on anything you may have missed.

Digital therapeutics help kids build emotional regulation and coping skills, supporting pediatric care while waiting for specialized mental health services.

Suicide was among the top 9 leading causes of death for people aged 10 to 64 years, and was the second leading cause of death for individuals aged 10 to 14 years and 25 to 34 years in 2022.

Using school-based approaches and staying in close contact with school personnel can increase overall care for the child.

Editor-in-chief Tina Tan, MD, FAAP, FIDSA, FPIDS, highlights the August 2024 issue of Contemporary Pediatrics.

The investigative team noted that teenagers with emotional and social support are better off to handle stressors such as biological and social transition, and are less likely to experience a variety of adverse physical and mental health outcomes.

A recent study reveals that maternal body mass index during pregnancy is associated with children's mid-childhood educational attainment, whereas maternal glucose status shows no significant impact.

A laboratory-based assessment shows children aged 18 - 32 months old were less likely to listen to attention prompts or their parent's requests when provided an iPad versus a standard toy.

Annie Certo, MA, and AJ Harris, MS, break down what a “summer slump” is and how it can affect children during summer break from school. The duo offers suggestions on how to combat the negative associations of a “summer slump.”

"Parents still ask about this. Indeed, many years ago the FDA approved a prescription form of a PUFA, Vayarin, for the treatment of patients with ADHD. It is no longer available, so I assume it did not work. There may be good reasons for taking a PUFA supplement, but having ADHD is not one of them." -Jon Matthew Farber, MD

A discussion evaluating how social media can impact an individual's mental health, and what specific elements of social media could be causing it.

The primary endpoint of the study was to measure childhood stigma related to disease visibility.

A retracted paper that erroneously claimed the measles, mumps and rubella (MMR) vaccine caused autism has repercussions still being felt today around topics such as vaccination, misinformation and disinformation, and measles incidence rates.

How providers can advocate for increased research determining social media and its association with youth mental health.

A discussion and explanation of metatarsus adductus, why screening is important, and the UNFO brace for treatment.

The national survey revealed parents are eager to learn more about school-based mental health services.

Compared with controls, children with CHD performed less well across all WISC-V indices and with large effect sizes for all indices and most subtests.

Overall, the findings of the study support the clinical utility of combining trio-WES sequencing with CNV-seq in the etiologic diagnosis and management of early-childhood GDD.

Though some drowning prevention strategies seem common or routine, data demonstrate drowning deaths among children have risen in recent years, which should prompt conversations with families on refreshers and new prevention initiatives.

Editor-in-chief Tina Tan, MD, FAAP, FIDSA, FPIDS, highlights the June 2024 issue of Contemporary Pediatrics.

The disorders can impact the academic and social functioning of college students and have been associated with long-term health issues.

The once daily extended-release oral suspension with nighttime dosing is approved to treat ADHD as a monotherapy or as an adjunctive therapy to approved CNS stimulant medications.